Article
Genotype, Mortality, Morbidity, and Outcomes of 3β-Hydroxysteroid Dehydrogenase Deficiency in Algeria.
Frontiers in endocrinology - 1 Jan 2022
Ladjouze Asmahane, Donaldson Malcolm, Plotton Ingrid, Djenane Nacima, Mohammedi Kahina, Tardy-Guidollet Véronique, Mallet Delphine, Boulesnane Kamélia, Bouzerar Zair, Morel Yves, Roucher-Boulez Florence
Abstract excerpt
Background: 3β-hydroxysteroid dehydrogenase 2 (3βHSD2) deficiency is a rare form of congenital adrenal hyperplasia (CAH), with fewer than 200 cases reported in the world literature and few data on outcomes. Patients and Methods: We report a mixed longitudinal and cross-sectional study from a single Algerian center between 2007 and 2021. Virilization and under-masculinization were assessed using Prader staging and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
